Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clouse, R. E.
Right arrow Articles by Carney, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clouse, R. E.
Right arrow Articles by Carney, R. M.
Related Collections
Right arrow Depression
Right arrow Sexual Medicine: Female
Right arrow Diabetes
Right arrow Coronary Artery Disease
Psychosomatic Medicine 65:376-383 (2003)
© 2003 American Psychosomatic Society


ORIGINAL ARTICLES

Depression and Coronary Heart Disease in Women With Diabetes

Ray E. Clouse, MD, Patrick J. Lustman, PhD, Kenneth E. Freedland, PhD, Linda S. Griffith, MSW, Janet B. McGill, MD and Robert M. Carney, PhD

From the Departments of Psychiatry (R.E.C., P.J.L., K.E.F., L.S.G., R.M.C.) and Medicine (R.E.C., J.B.McG), Washington University School of Medicine, and the Department of Veterans Affairs (P.J.L.), Medical Center, St. Louis, Missouri.

Address reprint requests to: Ray E. Clouse, MD, Professor of Medicine and Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8124, St. Louis, MO 63110. Email: rclouse{at}im.wustl.edu

OBJECTIVE: The protective effects of female gender on the appearance and course of coronary heart disease (CHD) in nondiabetic subjects are diminished in the presence of diabetes. Depression predicts onset of and poor outcome from CHD in nondiabetic populations. We hypothesized that the doubled rates of depression in female diabetic patients could help explain the high prevalence of CHD in women with diabetes.

METHOD: Seventy-six female type 1 and type 2 diabetic patients with (N=16) or without (N=60) active major depression (DSM-III) at index evaluation underwent systematic annual investigation of diabetes and its complications for up to 10 years. Occurrences of CHD and other macrovascular complications were examined in relation to depression status using survival analysis statistics. A multivariate model incorporating other CHD risk factors (age, duration of diabetes, body mass index, glycosylated hemoglobin, and presence of hypertension, hyperlipidemia, or tobacco use) was used to determine independent effects of depression on outcome.

RESULTS: Development of CHD was significantly more rapid in the depressed subset (p<0.01 between 10-year curves), an effect that persisted after controlling for base-line differences in body mass index. Depression also was retained as an independent predictor of CHD in the multivariate model with an age-adjusted hazard ratio of 5.2 (95% CI: 1.4–18.9; p=.01). In contrast, depression did not predict the development of clinically apparent peripheral or cerebrovascular disease.

CONCLUSIONS: In this sample of diabetic women, major depression was an independent risk factor that accelerated the development of CHD. Depression recognition and management may improve outcomes from diabetes in this gender subgroup.

Key Words: depression, • coronary heart disease, • diabetes, • peripheral vascular disease, • cerebrovascular disease.

Abbreviations: CHD = coronary heart disease;; DSM-III = Diagnostic and Statistical Manual of Mental Disorders, Version 3;; DIS = Diagnostic Interview Schedule, Version 3.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
M. M. Weissman, Y. Neria, M. J. Gameroff, D. J. Pilowsky, P. Wickramaratne, R. Lantigua, S. Shea, and M. Olfson
Positive Screens for Psychiatric Disorders in Primary Care: A Long-Term Follow-Up of Patients Who Were Not in Treatment
Psychiatr Serv, February 1, 2010; 61(2): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
Eval Health ProfHome page
J. Peters and K. Mengersen
Selective Reporting of Adjusted Estimates in Observational Epidemiology Studies: Reasons and Implications for Meta-analyses
Eval Health Prof, December 1, 2008; 31(4): 370 - 389.
[Abstract] [PDF]


Home page
J Am Board Fam MedHome page
W. A. Rush, R. R. Whitebird, M. R. Rush, L. I. Solberg, and P. J. O'Connor
Depression in Patients with Diabetes: Does It Impact Clinical Goals?
J Am Board Fam Med, September 1, 2008; 21(5): 392 - 397.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. M. Sanders, C. W. Wilkinson, G. J. Taborsky Jr., S. Al-Noori, W. Daumen, A. Zavosh, and D. P. Figlewicz
The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E853 - E860.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
Y. Chen, J. J Guo, H. Li, L. Wulsin, and N. C Patel
Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study
Ann. Pharmacother., February 1, 2008; 42(2): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
S. Penckofer, C. E. Ferrans, B. Velsor-Friedrich, and S. Savoy
The Psychological Impact of Living With Diabetes: Women's Day-to-Day Experiences
The Diabetes Educator, July 1, 2007; 33(4): 680 - 690.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. M. Williams, R. E. Clouse, B. D. Nix, E. H. Rubin, G. S. Sayuk, J. B. McGill, A. J. Gelenberg, P. S. Ciechanowski, I. B. Hirsch, and P. J. Lustman
Efficacy of Sertraline in Prevention of Depression Recurrence in Older Versus Younger Adults With Diabetes
Diabetes Care, April 1, 2007; 30(4): 801 - 806.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
P. M. Trief
Depression in Elderly Diabetes Patients
Diabetes Spectr, April 1, 2007; 20(2): 71 - 75.
[Full Text] [PDF]


Home page
Diabetes CareHome page
P. J. Lustman, M. M. Williams, G. S. Sayuk, B. D. Nix, and R. E. Clouse
Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion
Diabetes Care, March 1, 2007; 30(3): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
D. Anderson, C. Horton, M. L. O'Toole, C. A. Brownson, P. Fazzone, and E. B. Fisher
Integrating Depression Care With Diabetes Care in Real-World Settings: Lessons From the Robert Wood Johnson Foundation Diabetes Initiative
Diabetes Spectr, January 1, 2007; 20(1): 10 - 16.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Nicholson, H. Kuper, and H. Hemingway
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
Eur. Heart J., December 1, 2006; 27(23): 2763 - 2774.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. E. Elwing, P. J. Lustman, H. L. Wang, and R. E. Clouse
Depression, Anxiety, and Nonalcoholic Steatohepatitis
Psychosom Med, July 1, 2006; 68(4): 563 - 569.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
P. J. Lustman, R. E. Clouse, B. D. Nix, K. E. Freedland, E. H. Rubin, J. B. McGill, M. M. Williams, A. J. Gelenberg, P. S. Ciechanowski, and I. B. Hirsch
Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus: A Randomized, Double-blind, Placebo-Controlled Trial.
Arch Gen Psychiatry, May 1, 2006; 63(5): 521 - 529.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
M. M. Williams, R. E. Clouse, and P. J. Lustman
Treating Depression to Prevent Diabetes and Its Complications: Understanding Depression as a Medical Risk Factor
Clin. Diabetes, April 1, 2006; 24(2): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. M. Trief, P. C. Morin, R. Izquierdo, J. A. Teresi, J. P. Eimicke, R. Goland, J. Starren, S. Shea, and R. S. Weinstock
Depression and Glycemic Control in Elderly Ethnically Diverse Patients With Diabetes: The IDEATel Project
Diabetes Care, April 1, 2006; 29(4): 830 - 835.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
G. E. Miller, N. Rohleder, C. Stetler, and C. Kirschbaum
Clinical Depression and Regulation of the Inflammatory Response During Acute Stress
Psychosom Med, September 1, 2005; 67(5): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
T. Z. Naqvi, S. S.A. Naqvi, and C. N. B. Merz
Gender Differences in the Link Between Depression and Cardiovascular Disease
Psychosom Med, May 1, 2005; 67(Supplement_1): S15 - S18.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. A. Bell, S. L. Smith, T. A. Arcury, B. M. Snively, J. M. Stafford, and S. A. Quandt
Prevalence and Correlates of Depressive Symptoms Among Rural Older African Americans, Native Americans, and Whites With Diabetes
Diabetes Care, April 1, 2005; 28(4): 823 - 829.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
P. J. Lustman, R. E. Clouse, P. S. Ciechanowski, I. B. Hirsch, and K. E. Freedland
Depression-Related Hyperglycemia in Type 1 Diabetes: A Mediational Approach
Psychosom Med, March 1, 2005; 67(2): 195 - 199.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
P. J. Lustman and R. E. Clouse
Section III: Practical Considerations in the Management of Depression in Diabetes
Diabetes Spectr, July 1, 2004; 17(3): 160 - 166.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Psychosomatic Society